KIT and leukemia: These results indicated that FGFR3 deletion reprograms leukemia cells into CD117-positive leukemia cells by activating the FGFR1-ERG-CD117 signaling pathway, suggesting that FGFR1 signaling is essential for maintaining the pool of LSCs.